CAH Filing
4Filing Date: Apr 17, 2026

CARDINAL HEALTH INC (CAH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000721371-26-000015open_in_new
Total Value$79.2K
Trades1
Insiders1

Transaction Details

Hall Patricia Hemingway
Director·Direct
Grant · Acquire
Common Shares
Shares+381
Price$207.83
Total Value$79.2K
Shares Owned After28.64K
Transaction DateApr 15, 2026
Footnotes ▸

Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board. | Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026.

Post-Transaction Holdings

Hall Patricia Hemingway
SecuritySharesChange
Common Shares28.64K+381 (1.35%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: CARDINAL HEALTH INC (CAH) CIK: 0000721371 --- Reporting Owner --- Name: Hall Patricia Hemingway CIK: 0001517890 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Shares Date: 2026-04-15 | Code: A (Grant or award) Shares: +381 | Price: $207.83 Total Value: $79,183.23 Shares Owned After: 28,645 | Ownership: D (Direct) Footnotes: [F2] Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board. [F1] Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026. --- Footnotes (Complete Index) --- F1: Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026. F2: Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board. --- Signature --- /s/ /s/ Laura C. Dhaliwal, Attorney-in-fact (2026-04-17)

keid analysis is for reference only and does not constitute investment advice.